Search research articles
Contact Us
Filters
Showing results (211-220 of 402) with videos related to
Page
of 41
Sort By:
Gynecologic Oncology
|
May 1, 1993
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatment
M Markman, T Hakes, B Reichman, et al.
Cancer
|
February 15, 1993
Intraperitoneal chemotherapy in the management of ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Diethyldithiocarbamate chemoprotection of carboplatin--induced hematological toxicity
P Francis, M Markman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses
D Fennelly, J Schneider, D Spriggs, et al.
Gynecologic Oncology
|
December 11, 1992
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer
M Markman, B Reichman, T Hakes, et al.
American Journal of Obstetrics and Gynecology
|
May 20, 2005
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers
Dennis S Chi, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Gynecologic Oncology
|
December 8, 2004
A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?
Yukio Sonoda, Nadeem R Abu-Rustum, Mary L Gemignani, et al.
Gynecologic Oncology
|
September 24, 2013
Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy
Neil B Desai, Ana P Kiess, Marisa A Kollmeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 1992
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Seminars in Oncology
|
December 11, 1992
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
M Markman, T Hakes, B Reichman, et al.
Page
of 41
Search research articles
Search
Showing results (211-220 of 402) with videos related to
Sort By:
Page
of 41
Gynecologic Oncology
|
May 1, 1993
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatment
M Markman, T Hakes, B Reichman, et al.
Cancer
|
February 15, 1993
Intraperitoneal chemotherapy in the management of ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Diethyldithiocarbamate chemoprotection of carboplatin--induced hematological toxicity
P Francis, M Markman, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses
D Fennelly, J Schneider, D Spriggs, et al.
Gynecologic Oncology
|
December 11, 1992
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer
M Markman, B Reichman, T Hakes, et al.
American Journal of Obstetrics and Gynecology
|
May 20, 2005
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers
Dennis S Chi, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Gynecologic Oncology
|
December 8, 2004
A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?
Yukio Sonoda, Nadeem R Abu-Rustum, Mary L Gemignani, et al.
Gynecologic Oncology
|
September 24, 2013
Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy
Neil B Desai, Ana P Kiess, Marisa A Kollmeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 1992
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer
M Markman, B Reichman, T Hakes, et al.
Seminars in Oncology
|
December 11, 1992
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
M Markman, T Hakes, B Reichman, et al.
Page
of 41